Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 1,500
- Avg volume
- —
- Day's range
- $3.75 – $3.75
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People's Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interv...
Show more
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots in the People's Republic of China. The company offers Toumai laparoscopic surgical robot; Toumai single port laparoscopic surgical robot; DFVision 3D electronic laparoscope; SkyWalker orthopedic surgical robot; trans-bronchial surgical robot for natural orifice surgery; R-ONE vascular interventional robot for pan vascular surgery; and iSR'obot Mona Lisa robotic trans perineal prostate biopsy system. It is also involved in the distribution of surgical robot devices. The company was founded in 2014 and is headquartered in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 86 21 3895 4600
- Website
- https://www.medbotsurgical.com
- Address
- Building 1, Room 101, Area B 1601 Zhangdong Road China (Shanghai) Pilot Free Trade Zone, Shanghai, China
Latest news
No headlines yet.
